HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endoglin regulates renal ischaemia-reperfusion injury.

AbstractBACKGROUND:
Renal ischaemia-reperfusion (I-R) can cause acute tubular necrosis and chronic renal deterioration. Endoglin, an accessory receptor for Transforming Growth Factor-beta1 (TGF-beta1), is expressed on activated endothelium during macrophage maturation and implicated in the control of fibrosis, angiogenesis and inflammation.
METHODS:
Endoglin expression was monitored over 14 days after renal I-R in rats. As endoglin-null mice are not viable, the role of endoglin in I-R was studied by comparing renal I-R injury in haploinsufficient mice (Eng(+/-)) and their wild-type littermates (Eng(+/+)). Renal function, morphology and molecular markers of acute renal injury and inflammation were compared.
RESULTS:
Endoglin mRNA up-regulation in the post-ischaemic kidneys of rats occurred at 12 h after I-R; endoglin protein levels were elevated throughout the study period. Expression was initially localized to the vascular endothelium, then extended to fibrotic and inflamed areas of the interstitium. Two days after I-R, plasma creatinine elevation and acute tubular necrosis were less marked in Eng(+/-) than in Eng(+/+) mice. Significant up-regulation of endoglin protein was found only in the post-ischaemic kidneys of Eng(+/+) mice and coincided with an increased mRNA expression of the TGF-beta1 and collagen IV (alpha1) chain genes. Significant increases in vascular cell adhesion molecule-1 (VCAM-1) and inducible nitric oxide synthase (iNOS) expression, nitrosative stress, myeloperoxidase activity and CD68 staining for macrophages were evident in post-ischaemic kidneys of Eng(+/+), but not Eng(+/-) mice, suggesting that impaired endothelial activation and macrophage maturation may account for the reduced injury in post-ischaemic kidneys of Eng(+/-) mice.
CONCLUSIONS:
Endoglin is up-regulated in the post-ischaemic kidney and endoglin-haploinsufficient mice are protected from renal I-R injury. Endoglin may play a primary role in promoting inflammatory responses following renal I-R.
AuthorsNeil G Docherty, José M López-Novoa, Miguel Arevalo, Annette Düwel, Ana Rodriguez-Peña, Fernando Pérez-Barriocanal, Carmelo Bernabeu, Nélida Eleno
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant) Vol. 21 Issue 8 Pg. 2106-19 (Aug 2006) ISSN: 0931-0509 [Print] England
PMID16751653 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD68 protein, mouse
  • Collagen Type IV
  • Endoglin
  • Eng protein, mouse
  • Eng protein, rat
  • Intracellular Signaling Peptides and Proteins
  • RNA, Messenger
  • Transforming Growth Factor beta1
  • Vascular Cell Adhesion Molecule-1
  • Creatinine
  • Peroxidase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
Topics
  • Animals
  • Antigens, CD (biosynthesis, genetics)
  • Antigens, Differentiation, Myelomonocytic (biosynthesis, genetics)
  • Collagen Type IV (biosynthesis, genetics)
  • Creatinine (blood)
  • Endoglin
  • Endothelium, Vascular (metabolism, pathology)
  • Enzyme Induction
  • Fibrosis
  • Gene Expression Regulation
  • Heterozygote
  • Inflammation
  • Intracellular Signaling Peptides and Proteins (genetics, physiology)
  • Kidney (blood supply, metabolism, pathology)
  • Kidney Tubular Necrosis, Acute (etiology, physiopathology)
  • Macrophages (enzymology, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Monocytes (enzymology, pathology)
  • Nitric Oxide Synthase Type II (biosynthesis, genetics)
  • Peroxidase (analysis)
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (complications, physiopathology)
  • Transforming Growth Factor beta1 (biosynthesis, genetics)
  • Vascular Cell Adhesion Molecule-1 (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: